Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Harvard Business School
Baxter
Moodys
Fish and Richardson
Medtronic

Generated: April 19, 2019

DrugPatentWatch Database Preview

Tentative Approvals

« Back to Dashboard

Drugs with Tentative Approvals

Applicant Generic Name NDA Strength Dosage Form
Alembic Pharms Ltd pregabalin 203459 300MG CAPSULE;ORAL
Barr Labs Inc aripiprazole 078613 30MG TABLET; ORAL
Torrent Pharms Ltd valsartan; hydrochlorothiazide 091654 160MG; 12.5MG TABLET; ORAL
Mylan Pharms Inc sorafenib 207012 200MG TABLET;ORAL
Cipla Limited nevirapine 202212 100MG TABLET, FOR SUSPENSION; ORAL
Applicant Generic Name NDA Strength Dosage Form

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Moodys
Deloitte
Baxter
Colorcon
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.